Your Catalyst to a Lucrative Business
Regionally, North America dominated the global tissue engineering market in 2015 accounting for the
largest share. It is further projected to continue its dominance even during the forecast period. This can
be attributed to the presence of leading players in the region and high financial support for R&D from
the government as well as some private organizations. The Asia-Pacific region is expected to be the
most lucrative region in the near future. This is mainly because of the existence of immense manpower
and highly developed procedures coupled with government funding. The European market is said to
register reasonable growth prospects due to the presence of stringent regulatory rules.
Major players in the tissue engineering market are acquiring and working in partnerships with small-
scale companies so as to influence technology & research advancements and to expand the product
portfolio. Some of the key players include Sanofi S. A.; CryoLife Inc.; StemCells Inc.; and BioMimetic
Therapeutics Inc.
Table of Content
Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Tissue engineering - Industry summary and key buying criteria, 2016 - 2024
Chapter 3. Tissue Engineering Industry Outlook
3.1. Tissue engineering segmentation
3.2. Tissue engineering size and growth prospects
3.3. Tissue engineering dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Key opportunities prioritized
3.5. Industry analysis - Porter's
3.6. Tissue engineering PESTEL analysis, 2016
Continue…………..
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-report/tissue-engineering-
market
Follow Us: